These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25115926)

  • 21. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of plasmid-mediated quinolone resistance.
    Tran JH; Jacoby GA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5638-42. PubMed ID: 11943863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.
    Yamaguchi Y; Takei M; Kishii R; Yasuda M; Deguchi T
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1772-6. PubMed ID: 23357772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases.
    Richter SN; Giaretta G; Comuzzi V; Leo E; Mitchenall LA; Fisher LM; Maxwell A; Palumbo M
    Nucleic Acids Res; 2007; 35(18):6075-85. PubMed ID: 17766248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
    Yague G; Morris JE; Pan XS; Gould KA; Fisher LM
    Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of mutations in the gyrA and parC genes in Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from diseased food-producing animals.
    Liu BT; Liao XP; Yang SS; Wang XM; Li LL; Sun J; Yang YR; Fang LX; Li L; Zhao DH; Liu YH
    J Med Microbiol; 2012 Nov; 61(Pt 11):1591-1599. PubMed ID: 22878251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
    Vila J; Ruiz J; Goñi P; Jimenez de Anta T
    J Antimicrob Chemother; 1997 Jun; 39(6):757-62. PubMed ID: 9222045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topoisomerase IV catalysis and the mechanism of quinolone action.
    Anderson VE; Gootz TD; Osheroff N
    J Biol Chem; 1998 Jul; 273(28):17879-85. PubMed ID: 9651393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bypassing fluoroquinolone resistance with quinazolinediones: studies of drug-gyrase-DNA complexes having implications for drug design.
    Drlica K; Mustaev A; Towle TR; Luan G; Kerns RJ; Berger JM
    ACS Chem Biol; 2014 Dec; 9(12):2895-904. PubMed ID: 25310082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of ParC alpha4 helix with that of GyrA increases the stability and cytotoxicity of topoisomerase IV-quinolone-DNA ternary complexes.
    Pfeiffer ES; Hiasa H
    Antimicrob Agents Chemother; 2004 Feb; 48(2):608-11. PubMed ID: 14742217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.
    Vila J; Ruiz J; Goñi P; De Anta MT
    Antimicrob Agents Chemother; 1996 Feb; 40(2):491-3. PubMed ID: 8834907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
    Bagel S; Hüllen V; Wiedemann B; Heisig P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RuvAB branch migration complex can displace topoisomerase IV.quinolone.DNA ternary complexes.
    Shea ME; Hiasa H
    J Biol Chem; 2003 Nov; 278(48):48485-90. PubMed ID: 13679378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping E. coli Topoisomerase IV Binding and Activity Sites.
    El Sayyed H; Espéli O
    Methods Mol Biol; 2018; 1703():87-94. PubMed ID: 29177735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.